Suppr超能文献

白细胞介素-1受体拮抗剂和白细胞介素-6用于在临床表现出现前2天对新生儿败血症进行早期诊断。

Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation.

作者信息

Küster H, Weiss M, Willeitner A E, Detlefsen S, Jeremias I, Zbojan J, Geiger R, Lipowsky G, Simbruner G

机构信息

Children's Hospital, Kinderpoliklinik, University of Munich, Germany.

出版信息

Lancet. 1998 Oct 17;352(9136):1271-7. doi: 10.1016/S0140-6736(98)08148-3.

Abstract

BACKGROUND

Neonatal sepsis is a common and life-threatening disorder, particularly among preterm infants. Early initiation of antibiotic therapy is frequently delayed because the first clinical signs of sepsis are non-specific and there are no reliable early laboratory indicators. We investigated the time course of expression and the prognostic power of the early inflammatory mediators interleukin-1 receptor antagonist (IL-1ra), interleukin-6 (IL-6), and circulating intercellular adhesion molecule-1 (cICAM-1) before clinical diagnosis of sepsis.

METHODS

In a prospective multicentre study, we monitored 182 very-low-birthweight infants in six intensive-care units for occurrence of sepsis. During routine or clinically indicated blood sampling, an additional sample was collected for measurement of IL-1ra, IL-6, cICAM-1, and C-reactive protein (CRP). Infants were grouped into those with proven sepsis, no infection, or unclassified. The mean study duration was 34 days. Whenever sepsis occurred, a study period of 10 days was defined: day 0 was the day of clinical diagnosis of sepsis; days -4 to -1 were the 4 days before diagnosis; days +1 to +5 were the 5 days after. We compared the concentrations of the immune mediators during the 10-day study period with group-specific baseline values from before day -4.

FINDINGS

101 infants were included in the analysis: 21 with proven sepsis, 20 with no infection, and 60 unclassified. We excluded 57 because of incomplete datasets and 24 who had early-onset sepsis. IL-1ra and IL-6 increased significantly 2 days before diagnosis of sepsis; maximum median increases within the study period were 15-fold for IL-1ra and 12-fold for IL-6. The diagnostic sensitivities of IL-1ra, IL-6, and CRP concentrations on day 0 of diagnosis were 93%, 86%, and 43%, respectively; corresponding values on day -1 were 64%, 57%, and 18%. The specificities of IL-1ra, IL-6, and CRP concentrations were 92%, 83%, and 93%. cICAM-1 had a specificity of only 64%.

INTERPRETATION

IL-1ra and IL-6 are superior to cICAM-1 and CRP as predictors of sepsis 1 or more days before clinical diagnosis. Ad-hoc measurement of these cytokines could allow earlier initiation of antibiotic therapy with corresponding improvement in outcome in very-low-birthweight infants with sepsis.

摘要

背景

新生儿败血症是一种常见且危及生命的疾病,在早产儿中尤为常见。由于败血症的首发临床症状不具特异性且缺乏可靠的早期实验室指标,抗生素治疗的早期启动常常延迟。我们研究了败血症临床诊断前早期炎症介质白细胞介素-1受体拮抗剂(IL-1ra)、白细胞介素-6(IL-6)和循环细胞间黏附分子-1(cICAM-1)的表达时间进程及其预后价值。

方法

在一项前瞻性多中心研究中,我们在六个重症监护病房对182例极低出生体重儿进行败血症发生情况监测。在常规或临床指示的采血过程中,额外采集一份样本用于检测IL-1ra、IL-6、cICAM-1和C反应蛋白(CRP)。婴儿被分为确诊败血症组、无感染组或未分类组。平均研究时长为34天。每当发生败血症时,定义一个为期10天的研究期:第0天为败血症临床诊断日;第-4天至-1天为诊断前4天;第+1天至+5天为诊断后5天。我们将10天研究期内免疫介质的浓度与第-4天之前的组特异性基线值进行比较。

结果

101例婴儿纳入分析:21例确诊败血症,20例无感染,60例未分类。因数据集不完整排除57例,因早发型败血症排除24例。IL-1ra和IL-6在败血症诊断前2天显著升高;研究期内最大中位数增幅IL-1ra为15倍,IL-6为12倍。诊断第0天IL-1ra、IL-6和CRP浓度的诊断敏感性分别为93%、86%和43%;第-1天相应值分别为64%、57%和18%。IL-1ra、IL-6和CRP浓度的特异性分别为92%、83%和93%。cICAM-1的特异性仅为64%。

解读

在临床诊断前1天或更早,IL-1ra和IL-6作为败血症预测指标优于cICAM-1和CRP。对这些细胞因子进行临时检测可使极低出生体重败血症婴儿更早启动抗生素治疗,相应改善预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验